A potentially crippling medical condition, often dismissed by healthcare providers, can no longer be ignored. “Floxing”—a term for the adverse effects of fluoroquinolone antibiotics—has been officially recognized by the U.S. Centers for Disease Control and Prevention (CDC), a change driven in part by the advocacy of a local woman.
The CDC has launched a series of new ICD-10 (International Classification of Diseases, 10th Revision) codes specifically for Fluoroquinolone Poisoning. The codes are crucial for how healthcare systems document and track diseases, affecting everything from research to processing health insurance claims.
For Norwood resident Talia Smith, who has experienced life-altering symptoms after becoming sick the change is monumental…